Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP790769.RAynxyBEG1V1pljr_R8JyQzkWFLGg5UF048vInzqXO4Uc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP790769.RAynxyBEG1V1pljr_R8JyQzkWFLGg5UF048vInzqXO4Uc130_assertion type Assertion NP790769.RAynxyBEG1V1pljr_R8JyQzkWFLGg5UF048vInzqXO4Uc130_head.
- NP790769.RAynxyBEG1V1pljr_R8JyQzkWFLGg5UF048vInzqXO4Uc130_assertion wasGeneratedBy ECO_0000203 NP790769.RAynxyBEG1V1pljr_R8JyQzkWFLGg5UF048vInzqXO4Uc130_provenance.
- NP790769.RAynxyBEG1V1pljr_R8JyQzkWFLGg5UF048vInzqXO4Uc130_assertion wasDerivedFrom befree-20150227 NP790769.RAynxyBEG1V1pljr_R8JyQzkWFLGg5UF048vInzqXO4Uc130_provenance.
- NP790769.RAynxyBEG1V1pljr_R8JyQzkWFLGg5UF048vInzqXO4Uc130_assertion SIO_000772 18820675 NP790769.RAynxyBEG1V1pljr_R8JyQzkWFLGg5UF048vInzqXO4Uc130_provenance.
- NP790769.RAynxyBEG1V1pljr_R8JyQzkWFLGg5UF048vInzqXO4Uc130_assertion evidence source_evidence_literature NP790769.RAynxyBEG1V1pljr_R8JyQzkWFLGg5UF048vInzqXO4Uc130_provenance.
- NP790769.RAynxyBEG1V1pljr_R8JyQzkWFLGg5UF048vInzqXO4Uc130_assertion description "[Additionally, TCL1 expression was correlated with shorter time to treatment in chronic lymphocytic leukemia cases and shorter lymphoma-specific survival in mantle cell lymphoma series, thus indicating the clinical and biological significance of TCL1 expression, and suggesting TCL1A as a potential therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP790769.RAynxyBEG1V1pljr_R8JyQzkWFLGg5UF048vInzqXO4Uc130_provenance.